Prostate cancer Board decisions

The Veteran's sleep apnea and prostate cancer were denied as not related to service. The Board found that the Veteran's GERD, gastritis, right ring finger injury, and foot disability are secondary to his service-connected sinusitis.,Service connection for these conditions is being remanded due to insufficient medical opinions.

The Board has determined that additional evidence was added to the record since the last SSOC and remanded both claims for further development.

The Board has remanded the Veteran's claims for service connection for bilateral foot fungus and prostate cancer due to incomplete compliance with previous remand directives.

The Board has decided to remand the case due to insufficient compliance with previous directives and new arguments presented by the Veteran's representative.

The Board has determined that the reduction of the Veteran's prostate cancer rating from 100% to noncompensable effective January 1, 2016 was proper and completed in accordance with procedural requirements. The evidence does not support a compensable rating for prostate cancer residuals.

The Board has not found substantial compliance with its previous remand directive and requires further action to verify the Veteran's exposure to herbicide agents in Thailand.

The Veteran's application to reopen the previously denied claim of entitlement to service connection for diabetes mellitus was granted. Diabetes mellitus, type II is now presumed related to herbicide exposure in Thailand.,Prostate cancer on a presumptive basis due to herbicide agent exposure in Thailand is also granted.,Erectile dysfunction secondary to prostate cancer is granted.,The Veteran's claim for service connection of an acquired psychiatric disability (depression) is remanded.

The Veteran's service-connected disabilities rendered him unable to obtain and maintain gainful employment from March 11, 2014 to September 23, 2015. A total disability rating based on individual unemployability (TDIU) was granted for this period.

The Board has remanded the Veteran's claims of service connection for hypertension and prostate cancer due to incomplete development. The hypertension claim is inextricably intertwined with the prostate cancer claim.

The Board has remanded the cases of prostate cancer and Parkinson's disease due to insufficient evidence regarding the Veteran's exposure to herbicides during service.

The Board denied an initial compensable disability rating for the service-connected erectile dysfunction, finding that there was no indication of penile deformity and thus not meeting the criteria for a 20% rating under Diagnostic Code 7522.

The Veteran's claims for increased ratings for residuals of prostate cancer prior to April 8, 2021 and erectile dysfunction were denied. The Veteran's diabetes mellitus was rated at 20 percent.,The Veteran's claim for an initial compensable rating for erectile dysfunction was denied as there is no evidence of deformity of the penis. He is in receipt of special monthly compensation (SMC) k due to loss of use of a creative organ.

The Veteran's claims of entitlement to service connection for various conditions have been granted, with the exception that VA treatment records and private medical records are still needed.

The appeal for prostate cancer is dismissed. The Veteran's claim of service connection for an acquired psychiatric disorder, including PTSD, major depressive disorder, and anxiety disorder, is granted.

The Board denied service connection for prostate cancer, t-cell lymphoma, and erectile dysfunction. The Veteran's claims were based on presumed herbicide exposure during service in Thailand, but the evidence did not support such exposure.

The Board has granted service connection for diabetes mellitus, prostate cancer, and chronic lymphocytic leukemia on a presumptive basis due to exposure to herbicide agents during active duty in Thailand. The Veteran's claims for thyroid cancer are remanded.

The Board denied service connection for prostate cancer, diabetes mellitus type II, and peripheral neuropathy of the lower extremities as these conditions are not shown to be related to active service.

Service connection for Parkinson's disease and prostate cancer is granted.,The ED claim has been remanded due to unresolved issues.

The Veteran's bladder cancer is granted service connection as due to exposure to herbicide agents. The appeals for peripheral neuropathy are dismissed.

The Veteran's prostate cancer residuals are rated at 20 percent since December 1, 2018. The discontinuance of the 100% rating for prostate cancer is upheld as it was by operation of law.